BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Insmed Announces Additional Data from ALIS (Amikacin Liposome Inhalation Suspension) Phase III Clinical Program for Adult Patients with Treatment Refractory NTM Lung Disease Caused by MAC and Reports Progress With Commercial Preparations

  The company announced new data from its Phase 3 clinical program for adult patients with treatment refractory NTM lung disease.

  January 3, 2018

   · 

  18 min read
• Pharm Country

  Helius Medical Technologies Announces Closing of Second Tranche of Private Placement

  The net proceeds of the Private Placement will be used by the Company to finance the Company’s near-term operations.

  January 3, 2018

   · 

  6 min read
• Policy

  Applied BioCode Submits 510(k) Application to FDA for BioCode MDx-3000 with Gastrointestinal Pathogen Panel

  The BioCode MDx-3000 system was designed for high volume molecular testing in large hospitals and reference laboratories.

  January 3, 2018

   · 

  2 min read